Michael Ninburg
A5068220810- Hepatitis C virus research
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- HIV, Drug Use, Sexual Risk
- HIV/AIDS Research and Interventions
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
- Hepatocellular Carcinoma Treatment and Prognosis
- Diet, Metabolism, and Disease
- Artificial Intelligence in Healthcare
- Homelessness and Social Issues
- HIV/AIDS drug development and treatment
- Genetics, Bioinformatics, and Biomedical Research
- Advanced Causal Inference Techniques
- Global Health Care Issues
- Diabetes Management and Education
- Criminal Justice and Corrections Analysis
- Mental Health and Patient Involvement
Hepatitis B Foundation
2015-2023
Abstract The 69th World Health Assembly endorsed the Global Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as public health threat by 2030. This was followed Organization's (WHO) global targets care and management of B virus (HBV) C (HCV) infections. These announcements were important in raising awareness calling action; however, tracking countries’ progress towards these elimination goals has provided insights limitations targets. existing compare...
IMPORTANCE Hepatitis C virus (HCV) reinfection after curative treatment remains a concern for people who inject drugs. OBJECTIVE To assess the incidence of HCV and associated risk factors. DESIGN, SETTING, AND PARTICIPANTS This cohort study is secondary analysis randomized clinical trial that was conducted across opioid programs community health centers in US between September 2016 August 2018. The current analyses were performed March 2022. People drugs achieved sustained virologic response...
Abstract Background The advent of direct-acting antivirals (DAAs)—a form hepatitis C (HCV) treatment associated with shorter course and greater efficacy—offers an unprecedented opportunity to eliminate HCV, but only if care delivery systems are developed extend people who inject drugs (PWID). To support the design a community-pharmacy program, we explored perspectives PWID chronic HCV regard barriers, motivators, preferences, prior experiences related pharmacists. Methods We conducted...
Innovation contests are a novel approach to elicit good ideas and innovative practices in various areas of public health. There remains limited published literature on approaches deliver hepatitis testing. The purpose this innovation contest was identify examples different B C support countries their scale-up testing supplement development formal recommendations service delivery the 2017 World Health Organization guidelines.This involved four steps: 1) establishment multisectoral steering...
Hepatitis C virus (HCV) infection is common in the United States and leads to significant morbidity, mortality, economic costs. Simplified screening recommendations highly effective direct‐acting antivirals for HCV present an opportunity eliminate HCV. The objective of this study was increase testing, linkage care, treatment, cure This observational, prospective, population‐based intervention program carried out between September 2014 2018 performed three community health centers, large...
People who inject drugs (PWID) are a key population for treatment with direct-acting antiviral medications (DAAs) to eliminate hepatitis C virus (HCV). We developed Pharmacist, Physician, and Patient Navigator Collaborative Care Model (PPP-CCM) delivery of HCV treatment; this study describes clinical outcomes related (initial evaluation, initiation, completion, cure), as well patient satisfaction.